Login to Your Account



Scholar 'Rock on' $36M series B shows faith in growth factor activation

By Marie Powers
News Editor

Monday, January 4, 2016

Scholar Rock Inc., the 2-year-old company pursuing drugs that target supracellular activation of growth factors, jump-started its New Year with a $36 million series B financing.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription